AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
3.350
+0.050 (1.52%)
At close: Nov 10, 2025, 4:00 PM EST
3.350
0.00 (0.00%)
After-hours: Nov 10, 2025, 4:00 PM EST
AC Immune Market Cap
AC Immune has a market cap or net worth of $329.49 million as of November 10, 2025. Its market cap has increased by 8.89% in one year.
Market Cap
329.49M
Enterprise Value
204.24M
1-Year Change
8.89%
Ranking
Category
Stock Price
$3.35
Market Cap Chart
Since September 23, 2016, AC Immune's market cap has decreased from $867.50M to $329.49M, a decrease of -62.02%. That is a compound annual growth rate of -10.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 332.90M | 23.48% |
| Dec 31, 2024 | 269.60M | -36.36% |
| Dec 29, 2023 | 423.60M | 145.85% |
| Dec 30, 2022 | 172.30M | -52.25% |
| Dec 31, 2021 | 360.80M | -2.88% |
| Dec 31, 2020 | 371.50M | -35.46% |
| Dec 31, 2019 | 575.60M | 6.20% |
| Dec 31, 2018 | 542.00M | -25.42% |
| Dec 29, 2017 | 726.70M | 1.07% |
| Dec 30, 2016 | 719.00M | -17.12% |
| Sep 23, 2016 | 867.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 827.67B |
| Johnson & Johnson | 449.50B |
| AbbVie | 387.34B |
| UnitedHealth Group | 293.68B |
| AstraZeneca | 263.38B |
| Novartis AG | 243.48B |
| Abbott Laboratories | 219.72B |
| Thermo Fisher Scientific | 215.06B |